Table 1 Characteristics of data sets provided by participating centers of the German Consortium for Hereditary Breast & Ovarian Cancer (GC-HBOC), namely the Institute of Medical Genetics and Applied Genomics (IMGAG), University Hospital Tübingen, the Institute for Clinical Genetics (ICG), University Hospital Carl Gustav Carus Dresden, the Department of Medical Genetics (DMG), University Hospital Münster, the Center for Familial Breast and Ovarian Cancer (CFBOC), University Hospital Cologne, and the Institute of Human Genetics (IHG) at the University of Regensburg.

From: Limitations in next-generation sequencing-based genotyping of breast cancer polygenic risk score loci

 

IMGAG

ICG

DMG

CFBOC

IHG

Sample size

Set 1

348

585

545

412

251

Set 2

1410

Testing indication

 

Various

Cancer-related

Familial BC/OC

Familial BC/OC

Familial BC/OC

Considered PRS

 

BCAC 313

BCAC 313

BRIDGES 306

BRIDGES 306

BRIDGES 306

BRIDGES 306

NGS approach

 

WGS

Twist Custom

Cancer Panel

Twist Custom Panel

Agilent TruRisk v3

Agilent TruRisk v3

Reference

 

hg38

hg19

hg19

hg19

hg38

Variant caller

Set 1

DRAGEN v4.0.3

freebayes v1.3.6

DRAGEN v4.2.4

freebayes v1.3.6

CLC LightSpeed v23.0.2

Set 2

freebayes v1.3.6

GATK v4.2.6 HaplotypeCaller

GATK v4.4.0 HaplotypeCaller

GATK v4.3.2 HaplotypeCaller

GATK v4.2.6 HaplotypeCaller

Calling mode

Set 1

Unforced

Forced

Forced

Forced

Unforced

Set 2

Forced

Quality filter

 

DP ≥ 15

DP ≥ 20

DP ≥ 20

DP ≥ 30

DP ≥ 10

  1. Each center provided two data sets.
  2. BC/OC breast/ovarian cancer, DP sequencing depth, PRS polygenic risk score.